NCT07250841

Brief Summary

This observational study aims to screen Egyptian women aged 25-60 for cervical intraepithelial neoplasia (CIN) using liquid-based Pap smear during routine gynecological visits at Kasr Al-Aini outpatient clinics. Screening is performed through standardized liquid-based cytology to detect early cellular abnormalities that may indicate precancerous changes or cervical cancer. The goal of the study is to identify abnormal cytology at an early stage, improve early detection of cervical cancer, and provide epidemiological data on cervical abnormalities among women attending general gynecological services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
984

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 26, 2025

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

6 months

First QC Date

November 18, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

Liquid-Based CytologyPap SmearCervical ScreeningHPVCINCervical DysplasiaBethesda SystemGynecological ScreeningEgypt

Outcome Measures

Primary Outcomes (1)

  • Detection of Cervical Cytological Abnormalities

    Presence of cytological abnormalities detected using liquid-based cytology (ThinPrep) and interpreted according to the 2014 Bethesda System. Unit of measure: Percentage of participants Outcome measure tool: Liquid-based cytology (LBC) using ThinPrep; Bethesda System classification (ASC-US, LSIL, HSIL, NILM, Unsatisfactory).

    At time of screening (single visit)

Secondary Outcomes (2)

  • Prevalence of Abnormal Cervical Cytology

    At time of screening

  • Correlation Between Participant Characteristics and Abnormal Cytology

    At time of screening

Study Arms (1)

Gynecological Screening

Women aged 25-60 attending Kasr Al-Aini outpatient gynecology clinics who undergo liquid-based Pap smear screening for detection of cervical intraepithelial neoplasia.

Diagnostic Test: Liquid-Based Pap Smear (LBC)

Interventions

Cervical sample collected using a cervical brush or broom and preserved in liquid fixative solution. Slides prepared using ThinPrep liquid-based cytology and reported according to the 2014 Bethesda System. Used for detection of abnormal cervical cytology including ASC-US, LSIL, HSIL, and NILM.

Gynecological Screening

Eligibility Criteria

Age25 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly individuals who self-identify as female are eligible to participate, as the study involves cervical cytology screening and requires the presence of a cervix.
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women aged 25-60 attending Kasr Al-Aini outpatient gynecology clinics and undergoing routine cervical screening using liquid-based cytology.

You may qualify if:

  • Females aged 25-60
  • Attending Kasr Al-Aini outpatient gynecology clinics
  • Willing to provide informed consent

You may not qualify if:

  • Pregnancy
  • Prior hysterectomy
  • Existing cervical lesions
  • Previous CIN treatment in last 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Al-Aini Hospital - Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Uterine Cervical DysplasiaUterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by Site

Study Officials

  • Ahmed M El-Minawi, Professor

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Yossra Lasheen, Assistant Professor

    Cairo University

    STUDY CHAIR
  • Mohamed Aly, Lecturer

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Obstetrics and Gynecology Resident

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 26, 2025

Study Start

September 1, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

The study does not plan to share individual participant data. The collected data contain identifiable clinical information and cervical cytology results, and the ethics approval does not permit public release of raw participant-level data. Aggregated data may be available upon reasonable request.

Locations